May 25, 2017
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
Read More
January 23, 2017
RDR: Generic Xyrem to Treat Narcolepsy Gets FDA Approval
Read More
October 12, 2016
FDA Approves Lundbeck’s IV Carbamazepine For Certain Seizures
Read More
March 9, 2015
RARECast: Why the OPEN ACT Could Greatly Expand Treatments for Rare Disease
Read More
November 14, 2014
PDL BioPharma Buys Share of Cerdelga Royalties for $65.6M
Read More
October 14, 2013
FDA Approves Bayer’s New Class of Drug Adempas® for CTEHP
Read More
October 5, 2012
Biologics and TPP: Strong Protection of Proprietary Data is Necessary for the Development of Breakthrough Treatments
Read More
X